Last reviewed · How we verify
NCT05639244: SIGNATURE
Time Restricted Eating and Innate Immunity
NA trial testing Time restricted eating (TRE) in Time Restricted Feeding in 23 participants. Completed in 25 January 2024.
25 January 2024
Quick facts
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 23 |
| Start date | 17 November 2022 |
| Primary completion | 25 January 2024 |
| Estimated completion | 25 January 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Time restricted eating (TRE)
- Regular diet
Conditions studied
- Time Restricted Feeding — all drugs for Time Restricted Feeding →
- Myocardial Infarction — all drugs for Myocardial Infarction →
- Atherosclerotic Cardiovascular Disease — all drugs for Atherosclerotic Cardiovascular Disease →
Sponsor
Radboud University Medical Center
Who can join
18 and older, any sex, with Time Restricted Feeding or Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this cross over study is to investigate the effect of short term time restricted eating (TRE) on the innate immune system in patients with a history of myocardial infarction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05639244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Time restricted eating (TRE)
Trials testing the same drug.
- NCT06070194 — Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Extended Eating Period · NA · recruiting
Other recruiting trials for Time Restricted Feeding
Currently open trials in the same condition.
- NCT05628012 — Circadian Time Restricted Eating · NA · recruiting
- NCT05740254 — Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA) · NA · recruiting
Other Radboud University Medical Center trials
Trials by the same sponsor.
- NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
- NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
- NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
- NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
- NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05639244 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
- Last refreshed: 27 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05639244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing